Effexor xr and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Effexor xr (venlafaxine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for 5 - 10 years also take Seroquel, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Effexor xr. It is created by eHealthMe based on reports of 31,325 people who have side effects when taking Effexor xr from the FDA, and is updated regularly.

What is Effexor xr?

Effexor xr has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 35,233 Effexor xr users. Check the latest studies of Effexor xr.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 669 drugs and 1,641 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Jul, 06, 2026

31,325 people reported to have side effects when taking Effexor xr.
Among them, 82 people (0.26%) have Type 1 diabetes.

Among these 82 people:

How long have people been on Effexor xr when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Effexor xr? *

female: 59.49 %
male: 40.51 %

What is the age of people who have Type 1 diabetes when taking Effexor xr? *

What are other drugs people take besides Effexor xr? *

What are other side effects people have besides Type 1 diabetes? *

Diabetes: 51 people, 62.20%
Type 2 Diabetes: 48 people, 58.54%
Diabetes Mellitus Inadequate Control: 25 people, 30.49%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 20 people, 24.39%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 18 people, 21.95%
High Blood Cholesterol: 17 people, 20.73%
Hyperglycemia (high blood sugar): 15 people, 18.29%
Neuropathy Peripheral (surface nerve damage): 14 people, 17.07%
Hypoglycemia (low blood sugar): 14 people, 17.07%
Weight Increased: 11 people, 13.41%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 22 people, 26.83%
Sleep Disorder: 15 people, 18.29%
Pain: 14 people, 17.07%
Insomnia (sleeplessness): 11 people, 13.41%
Psychotic Disorder: 11 people, 13.41%
Affective Disorder (mental disorder): 8 people, 9.76%
High Blood Cholesterol: 7 people, 8.54%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 7.32%
High Blood Pressure: 6 people, 7.32%
Dizziness: 4 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor xr and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effexor xr:

Effexor xr (35,233 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

Browse all side effects of Effexor xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (669 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,641 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor xr) and Effexor xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.